

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | complement activation, alternative pathway (GO:0006957) | 9.49248291 |
| 2 | * exogenous drug catabolic process (GO:0042738) | 9.00455401 |
| 3 | * drug catabolic process (GO:0042737) | 8.84359740 |
| 4 | * epoxygenase P450 pathway (GO:0019373) | 8.57276742 |
| 5 | * omega-hydroxylase P450 pathway (GO:0097267) | 8.49976009 |
| 6 | regulation of protein activation cascade (GO:2000257) | 8.48667696 |
| 7 | regulation of fibrinolysis (GO:0051917) | 8.18384282 |
| 8 | glyoxylate metabolic process (GO:0046487) | 8.12291404 |
| 9 | regulation of complement activation (GO:0030449) | 8.05110320 |
| 10 | L-phenylalanine catabolic process (GO:0006559) | 7.98130125 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.98130125 |
| 12 | negative regulation of fibrinolysis (GO:0051918) | 7.64260684 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 7.25254388 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.25254388 |
| 15 | ethanol oxidation (GO:0006069) | 6.97905226 |
| 16 | urea metabolic process (GO:0019627) | 6.97816922 |
| 17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.86557282 |
| 18 | protein carboxylation (GO:0018214) | 6.86557282 |
| 19 | nitrogen cycle metabolic process (GO:0071941) | 6.33691722 |
| 20 | fibrinolysis (GO:0042730) | 6.27176913 |
| 21 | * drug metabolic process (GO:0017144) | 6.24753932 |
| 22 | blood coagulation, intrinsic pathway (GO:0007597) | 6.15807504 |
| 23 | bile acid biosynthetic process (GO:0006699) | 6.07892505 |
| 24 | aromatic amino acid family catabolic process (GO:0009074) | 5.99799997 |
| 25 | urea cycle (GO:0000050) | 5.89056935 |
| 26 | serine family amino acid catabolic process (GO:0009071) | 5.88292601 |
| 27 | cellular glucuronidation (GO:0052695) | 5.72273024 |
| 28 | imidazole-containing compound metabolic process (GO:0052803) | 5.66773382 |
| 29 | protein activation cascade (GO:0072376) | 5.66354290 |
| 30 | ethanol metabolic process (GO:0006067) | 5.62646003 |
| 31 | opsonization (GO:0008228) | 5.57784569 |
| 32 | complement activation (GO:0006956) | 5.50065459 |
| 33 | regulation of triglyceride catabolic process (GO:0010896) | 5.49649785 |
| 34 | uronic acid metabolic process (GO:0006063) | 5.43180487 |
| 35 | glucuronate metabolic process (GO:0019585) | 5.43180487 |
| 36 | complement activation, classical pathway (GO:0006958) | 5.39332518 |
| 37 | phenylpropanoid metabolic process (GO:0009698) | 5.39188493 |
| 38 | bile acid metabolic process (GO:0008206) | 5.37884684 |
| 39 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.37055542 |
| 40 | negative regulation of sterol transport (GO:0032372) | 5.28097189 |
| 41 | negative regulation of cholesterol transport (GO:0032375) | 5.28097189 |
| 42 | regulation of plasminogen activation (GO:0010755) | 5.17639892 |
| 43 | * oxidative demethylation (GO:0070989) | 5.12468586 |
| 44 | regulation of humoral immune response (GO:0002920) | 5.12162997 |
| 45 | glycine metabolic process (GO:0006544) | 5.09770525 |
| 46 | acute-phase response (GO:0006953) | 4.94912855 |
| 47 | negative regulation of protein activation cascade (GO:2000258) | 4.91343569 |
| 48 | bile acid and bile salt transport (GO:0015721) | 4.89837450 |
| 49 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.86210875 |
| 50 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.86210875 |
| 51 | cytolysis (GO:0019835) | 4.83017003 |
| 52 | S-adenosylmethionine metabolic process (GO:0046500) | 4.79452106 |
| 53 | negative regulation of hemostasis (GO:1900047) | 4.71514135 |
| 54 | negative regulation of blood coagulation (GO:0030195) | 4.71514135 |
| 55 | tyrosine metabolic process (GO:0006570) | 4.67889252 |
| 56 | glutamate metabolic process (GO:0006536) | 4.44028624 |
| 57 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.41243409 |
| 58 | triglyceride homeostasis (GO:0070328) | 4.40622881 |
| 59 | acylglycerol homeostasis (GO:0055090) | 4.40622881 |
| 60 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.33224105 |
| 61 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.33224105 |
| 62 | negative regulation of coagulation (GO:0050819) | 4.28707936 |
| 63 | negative regulation of wound healing (GO:0061045) | 4.26703907 |
| 64 | alkaloid metabolic process (GO:0009820) | 4.26653711 |
| 65 | indole-containing compound catabolic process (GO:0042436) | 4.23506550 |
| 66 | indolalkylamine catabolic process (GO:0046218) | 4.23506550 |
| 67 | tryptophan catabolic process (GO:0006569) | 4.23506550 |
| 68 | plasma lipoprotein particle remodeling (GO:0034369) | 4.16735429 |
| 69 | protein-lipid complex remodeling (GO:0034368) | 4.16735429 |
| 70 | macromolecular complex remodeling (GO:0034367) | 4.16735429 |
| 71 | alpha-amino acid catabolic process (GO:1901606) | 4.12011044 |
| 72 | amino-acid betaine metabolic process (GO:0006577) | 4.08326969 |
| 73 | serine family amino acid metabolic process (GO:0009069) | 4.05922415 |
| 74 | phospholipid efflux (GO:0033700) | 4.05158374 |
| 75 | positive regulation of blood coagulation (GO:0030194) | 4.03931352 |
| 76 | positive regulation of hemostasis (GO:1900048) | 4.03931352 |
| 77 | arginine metabolic process (GO:0006525) | 4.01084872 |
| 78 | negative regulation of complement activation (GO:0045916) | 4.00736943 |
| 79 | cholesterol efflux (GO:0033344) | 3.98829602 |
| 80 | hormone catabolic process (GO:0042447) | 3.97467754 |
| 81 | high-density lipoprotein particle remodeling (GO:0034375) | 3.92493026 |
| 82 | aromatic amino acid family metabolic process (GO:0009072) | 3.91131654 |
| 83 | flavonoid metabolic process (GO:0009812) | 3.90522331 |
| 84 | cellular ketone body metabolic process (GO:0046950) | 3.88676441 |
| 85 | regulation of cholesterol esterification (GO:0010872) | 3.75590084 |
| 86 | positive regulation of coagulation (GO:0050820) | 3.71071681 |
| 87 | acute inflammatory response (GO:0002526) | 3.67429126 |
| 88 | negative regulation of lipase activity (GO:0060192) | 3.66907766 |
| 89 | reverse cholesterol transport (GO:0043691) | 3.60162673 |
| 90 | tryptophan metabolic process (GO:0006568) | 3.59138454 |
| 91 | regulation of acute inflammatory response (GO:0002673) | 3.58212317 |
| 92 | serine family amino acid biosynthetic process (GO:0009070) | 3.57211451 |
| 93 | cellular amino acid catabolic process (GO:0009063) | 3.53348117 |
| 94 | sodium-independent organic anion transport (GO:0043252) | 3.50165386 |
| 95 | response to mercury ion (GO:0046689) | 3.50067827 |
| 96 | * xenobiotic metabolic process (GO:0006805) | 3.47397689 |
| 97 | heme transport (GO:0015886) | 3.45841918 |
| 98 | intestinal cholesterol absorption (GO:0030299) | 3.40804765 |
| 99 | ketone body metabolic process (GO:1902224) | 3.40686955 |
| 100 | regulation of apoptotic cell clearance (GO:2000425) | 3.39826431 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.10302552 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.93996690 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.72599407 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.69463394 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.40037484 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.86128820 |
| 7 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.67583964 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.04663752 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.83764654 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.72527875 |
| 11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07881888 |
| 12 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.06971805 |
| 13 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.01333721 |
| 14 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.00930949 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.2572605 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.83967039 |
| 17 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.66329924 |
| 18 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.32821894 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29534653 |
| 20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.29304493 |
| 21 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.24806509 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19212268 |
| 23 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.15460086 |
| 24 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.08439396 |
| 25 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.05405053 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.01854761 |
| 27 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.01416540 |
| 28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.97852552 |
| 29 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.95807017 |
| 30 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93874333 |
| 31 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.93711227 |
| 32 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.93506631 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.93051557 |
| 34 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.92785866 |
| 35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.89654504 |
| 36 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.88737659 |
| 37 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.87746596 |
| 38 | GATA1_22025678_ChIP-Seq_K562_Human | 0.87320818 |
| 39 | NFYA_21822215_ChIP-Seq_K562_Human | 0.86175104 |
| 40 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.85620295 |
| 41 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.85069806 |
| 42 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.83676779 |
| 43 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81989599 |
| 44 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.80780817 |
| 45 | AR_20517297_ChIP-Seq_VCAP_Human | 0.80347076 |
| 46 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.79948115 |
| 47 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.79229439 |
| 48 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.78777013 |
| 49 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78668542 |
| 50 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.74830406 |
| 51 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74605719 |
| 52 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.73753024 |
| 53 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.72877462 |
| 54 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.71908846 |
| 55 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.71506399 |
| 56 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.70019154 |
| 57 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.69332845 |
| 58 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.69259444 |
| 59 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.69252415 |
| 60 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.69216539 |
| 61 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.65823113 |
| 62 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.65299814 |
| 63 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.62554400 |
| 64 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.62480576 |
| 65 | NFYB_21822215_ChIP-Seq_K562_Human | 0.61338804 |
| 66 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.61158733 |
| 67 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.60954144 |
| 68 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.59231717 |
| 69 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.58575111 |
| 70 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.58402445 |
| 71 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.57593952 |
| 72 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.57046855 |
| 73 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.57028180 |
| 74 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.56699358 |
| 75 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.55992465 |
| 76 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.55878692 |
| 77 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.54545918 |
| 78 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.54391724 |
| 79 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.54256129 |
| 80 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.54256129 |
| 81 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.54245356 |
| 82 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.53779199 |
| 83 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.53131693 |
| 84 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.52756166 |
| 85 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.52622218 |
| 86 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.52473918 |
| 87 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.52463791 |
| 88 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.52073245 |
| 89 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.51967091 |
| 90 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.51557202 |
| 91 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.51232166 |
| 92 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.51041773 |
| 93 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.51016232 |
| 94 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.50986342 |
| 95 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.50761830 |
| 96 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.50281371 |
| 97 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.50218589 |
| 98 | NCOR_22424771_ChIP-Seq_293T_Human | 0.48806625 |
| 99 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.48349889 |
| 100 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.48349889 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.73162760 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 6.38074495 |
| 3 | MP0005360_urolithiasis | 6.13538356 |
| 4 | MP0008875_abnormal_xenobiotic_pharmacok | 6.07651621 |
| 5 | MP0005365_abnormal_bile_salt | 5.62529867 |
| 6 | MP0003195_calcinosis | 5.00919546 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 4.81655275 |
| 8 | MP0003252_abnormal_bile_duct | 4.30415730 |
| 9 | MP0001666_abnormal_nutrient_absorption | 3.06872451 |
| 10 | MP0003868_abnormal_feces_composition | 2.95206496 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.85657010 |
| 12 | MP0009697_abnormal_copulation | 2.67195599 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.60265639 |
| 14 | MP0005332_abnormal_amino_acid | 2.44627137 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.31325333 |
| 16 | MP0010368_abnormal_lymphatic_system | 2.10068056 |
| 17 | MP0009840_abnormal_foam_cell | 1.86165354 |
| 18 | MP0000609_abnormal_liver_physiology | 1.85470113 |
| 19 | MP0002876_abnormal_thyroid_physiology | 1.76726851 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.70332825 |
| 21 | MP0001764_abnormal_homeostasis | 1.66149807 |
| 22 | MP0005670_abnormal_white_adipose | 1.42475814 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 1.32707689 |
| 24 | MP0001661_extended_life_span | 1.30559323 |
| 25 | MP0002132_abnormal_respiratory_system | 1.25654284 |
| 26 | MP0009053_abnormal_anal_canal | 1.17968259 |
| 27 | MP0005319_abnormal_enzyme/_coenzyme | 1.10624739 |
| 28 | MP0005408_hypopigmentation | 1.10435723 |
| 29 | MP0000598_abnormal_liver_morphology | 1.08377164 |
| 30 | MP0009764_decreased_sensitivity_to | 1.06337632 |
| 31 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.97303536 |
| 32 | MP0003656_abnormal_erythrocyte_physiolo | 0.97043924 |
| 33 | MP0009643_abnormal_urine_homeostasis | 0.94970375 |
| 34 | MP0009763_increased_sensitivity_to | 0.91835517 |
| 35 | MP0002282_abnormal_trachea_morphology | 0.88019124 |
| 36 | MP0005187_abnormal_penis_morphology | 0.85314013 |
| 37 | MP0005376_homeostasis/metabolism_phenot | 0.84795875 |
| 38 | MP0002971_abnormal_brown_adipose | 0.84452036 |
| 39 | MP0009642_abnormal_blood_homeostasis | 0.84377486 |
| 40 | MP0000604_amyloidosis | 0.81765067 |
| 41 | MP0003186_abnormal_redox_activity | 0.79229544 |
| 42 | MP0008872_abnormal_physiological_respon | 0.78619098 |
| 43 | MP0001915_intracranial_hemorrhage | 0.77624179 |
| 44 | MP0008469_abnormal_protein_level | 0.77033242 |
| 45 | MP0003690_abnormal_glial_cell | 0.72610201 |
| 46 | MP0005636_abnormal_mineral_homeostasis | 0.72138804 |
| 47 | MP0005395_other_phenotype | 0.69833958 |
| 48 | MP0005535_abnormal_body_temperature | 0.68178796 |
| 49 | MP0002168_other_aberrant_phenotype | 0.67253491 |
| 50 | MP0005266_abnormal_metabolism | 0.66724475 |
| 51 | MP0005451_abnormal_body_composition | 0.65119543 |
| 52 | MP0003011_delayed_dark_adaptation | 0.63337031 |
| 53 | MP0002078_abnormal_glucose_homeostasis | 0.63246716 |
| 54 | MP0002249_abnormal_larynx_morphology | 0.62281205 |
| 55 | MP0003879_abnormal_hair_cell | 0.60464250 |
| 56 | MP0005464_abnormal_platelet_physiology | 0.60115924 |
| 57 | MP0008874_decreased_physiological_sensi | 0.57434281 |
| 58 | MP0005334_abnormal_fat_pad | 0.55376528 |
| 59 | MP0003638_abnormal_response/metabolism_ | 0.51463759 |
| 60 | MP0009785_altered_susceptibility_to | 0.50533929 |
| 61 | MP0004130_abnormal_muscle_cell | 0.50340082 |
| 62 | MP0005023_abnormal_wound_healing | 0.49099856 |
| 63 | MP0009765_abnormal_xenobiotic_induced | 0.47226095 |
| 64 | MP0005166_decreased_susceptibility_to | 0.45478240 |
| 65 | MP0000566_synostosis | 0.45405954 |
| 66 | MP0002332_abnormal_exercise_endurance | 0.43837216 |
| 67 | MP0000249_abnormal_blood_vessel | 0.39992452 |
| 68 | MP0005448_abnormal_energy_balance | 0.37843228 |
| 69 | MP0006036_abnormal_mitochondrial_physio | 0.37653133 |
| 70 | MP0003075_altered_response_to | 0.37486226 |
| 71 | MP0000639_abnormal_adrenal_gland | 0.37443806 |
| 72 | MP0005164_abnormal_response_to | 0.34825091 |
| 73 | MP0002136_abnormal_kidney_physiology | 0.34427772 |
| 74 | MP0005220_abnormal_exocrine_pancreas | 0.34379968 |
| 75 | MP0004883_abnormal_blood_vessel | 0.33906029 |
| 76 | MP0002928_abnormal_bile_duct | 0.33143282 |
| 77 | MP0009115_abnormal_fat_cell | 0.31645494 |
| 78 | MP0004782_abnormal_surfactant_physiolog | 0.30556567 |
| 79 | MP0003953_abnormal_hormone_level | 0.30195854 |
| 80 | MP0000467_abnormal_esophagus_morphology | 0.28844003 |
| 81 | MP0005083_abnormal_biliary_tract | 0.27451695 |
| 82 | MP0005397_hematopoietic_system_phenotyp | 0.25470603 |
| 83 | MP0001545_abnormal_hematopoietic_system | 0.25470603 |
| 84 | MP0005058_abnormal_lysosome_morphology | 0.24932328 |
| 85 | MP0005647_abnormal_sex_gland | 0.24237481 |
| 86 | MP0005084_abnormal_gallbladder_morpholo | 0.24011377 |
| 87 | MP0002128_abnormal_blood_circulation | 0.22884585 |
| 88 | MP0001944_abnormal_pancreas_morphology | 0.22693743 |
| 89 | MP0001845_abnormal_inflammatory_respons | 0.22100139 |
| 90 | MP0001756_abnormal_urination | 0.21308776 |
| 91 | MP0001851_eye_inflammation | 0.20749557 |
| 92 | MP0001986_abnormal_taste_sensitivity | 0.20074394 |
| 93 | MP0003705_abnormal_hypodermis_morpholog | 0.18795923 |
| 94 | MP0005646_abnormal_pituitary_gland | 0.18728139 |
| 95 | MP0003633_abnormal_nervous_system | 0.18583264 |
| 96 | MP0008873_increased_physiological_sensi | 0.17797176 |
| 97 | MP0005666_abnormal_adipose_tissue | 0.17476537 |
| 98 | MP0005197_abnormal_uvea_morphology | 0.17128283 |
| 99 | MP0004142_abnormal_muscle_tone | 0.16555600 |
| 100 | MP0002135_abnormal_kidney_morphology | 0.16460892 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 9.97792544 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 9.27993138 |
| 3 | Abnormality of complement system (HP:0005339) | 8.68803965 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 8.17060520 |
| 5 | Conjugated hyperbilirubinemia (HP:0002908) | 7.37210529 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 7.33620711 |
| 7 | Joint hemorrhage (HP:0005261) | 6.70235654 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 6.54349720 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.73888396 |
| 10 | Intrahepatic cholestasis (HP:0001406) | 5.64911009 |
| 11 | Glomerulonephritis (HP:0000099) | 5.40403933 |
| 12 | Abnormality of pyrimidine metabolism (HP:0004353) | 5.20308426 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.17202551 |
| 14 | Xanthomatosis (HP:0000991) | 4.85528748 |
| 15 | Spontaneous abortion (HP:0005268) | 4.67228879 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.59536059 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.35665045 |
| 18 | Abnormality of the intrinsic pathway (HP:0010989) | 4.33783842 |
| 19 | Nephritis (HP:0000123) | 4.00507653 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.84011015 |
| 21 | Abnormality of methionine metabolism (HP:0010901) | 3.56597535 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 3.49503329 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.29388004 |
| 24 | Hyperglycinemia (HP:0002154) | 3.23913983 |
| 25 | Fat malabsorption (HP:0002630) | 3.21920669 |
| 26 | Hyperammonemia (HP:0001987) | 3.13567312 |
| 27 | Gingival bleeding (HP:0000225) | 3.12015660 |
| 28 | Delayed CNS myelination (HP:0002188) | 2.92228633 |
| 29 | Neonatal hypoglycemia (HP:0001998) | 2.89647265 |
| 30 | Osteomalacia (HP:0002749) | 2.88315507 |
| 31 | Generalized aminoaciduria (HP:0002909) | 2.87881477 |
| 32 | Hypercholesterolemia (HP:0003124) | 2.85089452 |
| 33 | Abnormality of nucleobase metabolism (HP:0010932) | 2.84073198 |
| 34 | Abnormality of glycine metabolism (HP:0010895) | 2.77443647 |
| 35 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.77443647 |
| 36 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.74797360 |
| 37 | Hyperbilirubinemia (HP:0002904) | 2.70541729 |
| 38 | Thrombophlebitis (HP:0004418) | 2.68816737 |
| 39 | Epidermoid cyst (HP:0200040) | 2.65599258 |
| 40 | Fair hair (HP:0002286) | 2.63442252 |
| 41 | Hepatocellular carcinoma (HP:0001402) | 2.60982680 |
| 42 | Mitral stenosis (HP:0001718) | 2.52017590 |
| 43 | Abnormality of serum amino acid levels (HP:0003112) | 2.50176426 |
| 44 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.49047171 |
| 45 | Vascular calcification (HP:0004934) | 2.48605890 |
| 46 | Rickets (HP:0002748) | 2.46314895 |
| 47 | Hemorrhage of the eye (HP:0011885) | 2.42076051 |
| 48 | Pulmonary embolism (HP:0002204) | 2.39801048 |
| 49 | Purpura (HP:0000979) | 2.37847209 |
| 50 | Hyperglycinuria (HP:0003108) | 2.31675738 |
| 51 | Steatorrhea (HP:0002570) | 2.31500985 |
| 52 | Menorrhagia (HP:0000132) | 2.29135907 |
| 53 | Cholelithiasis (HP:0001081) | 2.19174007 |
| 54 | Cardiovascular calcification (HP:0011915) | 2.19108552 |
| 55 | Reduced antithrombin III activity (HP:0001976) | 2.15401767 |
| 56 | Metabolic acidosis (HP:0001942) | 2.12420416 |
| 57 | Abnormal gallbladder morphology (HP:0012437) | 2.07784988 |
| 58 | Ketosis (HP:0001946) | 2.03845448 |
| 59 | Hyperphosphaturia (HP:0003109) | 2.02840702 |
| 60 | Complement deficiency (HP:0004431) | 10.8288906 |
| 61 | Deep venous thrombosis (HP:0002625) | 10.0226905 |
| 62 | Elevated alkaline phosphatase (HP:0003155) | 1.98897293 |
| 63 | Cholecystitis (HP:0001082) | 1.95696502 |
| 64 | Abnormal gallbladder physiology (HP:0012438) | 1.95696502 |
| 65 | Joint swelling (HP:0001386) | 1.95122526 |
| 66 | Abnormality of vitamin metabolism (HP:0100508) | 1.87236470 |
| 67 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.85373366 |
| 68 | Irritability (HP:0000737) | 1.84226346 |
| 69 | Generalized hypopigmentation of hair (HP:0011358) | 1.82992018 |
| 70 | Arthropathy (HP:0003040) | 1.81687474 |
| 71 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.81342033 |
| 72 | Increased serum ferritin (HP:0003281) | 1.80503020 |
| 73 | Abnormality of iron homeostasis (HP:0011031) | 1.80084092 |
| 74 | Myocardial infarction (HP:0001658) | 1.78729770 |
| 75 | Abnormality of urine glucose concentration (HP:0011016) | 1.77386776 |
| 76 | Glycosuria (HP:0003076) | 1.77386776 |
| 77 | Epistaxis (HP:0000421) | 1.76999561 |
| 78 | Abnormality of purine metabolism (HP:0004352) | 1.75798719 |
| 79 | Abnormal biliary tract physiology (HP:0012439) | 1.72784227 |
| 80 | Bile duct proliferation (HP:0001408) | 1.72784227 |
| 81 | Gangrene (HP:0100758) | 1.70807806 |
| 82 | Gout (HP:0001997) | 1.70160145 |
| 83 | Skin nodule (HP:0200036) | 1.69191482 |
| 84 | Blue irides (HP:0000635) | 1.66791856 |
| 85 | Cerebral palsy (HP:0100021) | 1.66212314 |
| 86 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.65662229 |
| 87 | Enlarged kidneys (HP:0000105) | 1.64823052 |
| 88 | Abnormality of the Achilles tendon (HP:0005109) | 1.64305036 |
| 89 | Hypophosphatemic rickets (HP:0004912) | 1.61396639 |
| 90 | Abnormal urine phosphate concentration (HP:0012599) | 1.60962572 |
| 91 | Increased mean platelet volume (HP:0011877) | 1.56329637 |
| 92 | Lethargy (HP:0001254) | 1.54246748 |
| 93 | Bifid scrotum (HP:0000048) | 1.53910298 |
| 94 | Atrioventricular block (HP:0001678) | 1.53851615 |
| 95 | Poikilocytosis (HP:0004447) | 1.51109512 |
| 96 | Pancreatitis (HP:0001733) | 1.50147641 |
| 97 | Abnormal delivery (HP:0001787) | 1.49618714 |
| 98 | Abnormality of the gallbladder (HP:0005264) | 1.48081077 |
| 99 | Alkalosis (HP:0001948) | 1.42280363 |
| 100 | Hypochromic microcytic anemia (HP:0004840) | 1.41714185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.24754478 |
| 2 | PIK3CG | 4.72906045 |
| 3 | FGFR4 | 3.89987024 |
| 4 | RIPK1 | 3.08372952 |
| 5 | TRIB3 | 2.75624597 |
| 6 | SIK1 | 2.60974478 |
| 7 | BCKDK | 2.56570580 |
| 8 | TYK2 | 2.52586327 |
| 9 | PIK3CA | 2.45310782 |
| 10 | PRKACG | 2.41699336 |
| 11 | NTRK3 | 2.31084056 |
| 12 | EPHA3 | 2.16399183 |
| 13 | MAP2K4 | 2.11276767 |
| 14 | PRKAA2 | 1.93324207 |
| 15 | TNK2 | 1.69060193 |
| 16 | PRKCG | 1.63320408 |
| 17 | TAOK3 | 1.58223983 |
| 18 | PINK1 | 1.57975163 |
| 19 | FGFR3 | 1.52738643 |
| 20 | MAPK11 | 1.50615761 |
| 21 | MAP3K3 | 1.44204569 |
| 22 | NLK | 1.42072219 |
| 23 | IGF1R | 1.40356665 |
| 24 | PRPF4B | 1.40086750 |
| 25 | EPHB1 | 1.34519741 |
| 26 | JAK1 | 1.32830396 |
| 27 | FRK | 1.30802822 |
| 28 | PDPK1 | 1.22155034 |
| 29 | TIE1 | 1.20514241 |
| 30 | ERBB2 | 1.20256919 |
| 31 | FER | 1.20181436 |
| 32 | MAP3K2 | 1.15696020 |
| 33 | NEK9 | 1.13484456 |
| 34 | MST1R | 1.11279543 |
| 35 | ABL2 | 1.09746238 |
| 36 | PRKCZ | 1.04362051 |
| 37 | WNK3 | 1.00319975 |
| 38 | PRKACA | 1.00135693 |
| 39 | MAP3K1 | 1.00110080 |
| 40 | FGFR2 | 0.99755155 |
| 41 | PRKG1 | 0.99636962 |
| 42 | JAK2 | 0.97442438 |
| 43 | BLK | 0.97162260 |
| 44 | MAP3K6 | 0.92091962 |
| 45 | DAPK2 | 0.90343242 |
| 46 | PKN2 | 0.89186751 |
| 47 | INSRR | 0.88249278 |
| 48 | EPHA4 | 0.88184337 |
| 49 | KDR | 0.87143855 |
| 50 | STK16 | 0.86999285 |
| 51 | PDK1 | 0.85298432 |
| 52 | TBK1 | 0.85153091 |
| 53 | CAMKK2 | 0.84581284 |
| 54 | PRKAA1 | 0.83831331 |
| 55 | MYLK | 0.82196374 |
| 56 | CSF1R | 0.80629439 |
| 57 | RET | 0.78194599 |
| 58 | SGK494 | 0.74529932 |
| 59 | SGK223 | 0.74529932 |
| 60 | SGK2 | 0.74283475 |
| 61 | AKT3 | 0.71341022 |
| 62 | MAPK7 | 0.68705964 |
| 63 | MAPK12 | 0.67104157 |
| 64 | PRKCA | 0.65769105 |
| 65 | RPS6KA3 | 0.64379116 |
| 66 | CSNK1D | 0.64354506 |
| 67 | GRK1 | 0.60477258 |
| 68 | PDK2 | 0.60296489 |
| 69 | PRKCB | 0.60064089 |
| 70 | PRKACB | 0.59486577 |
| 71 | CAMKK1 | 0.57877477 |
| 72 | SGK3 | 0.57556702 |
| 73 | CDK6 | 0.57067968 |
| 74 | ARAF | 0.56058737 |
| 75 | SGK1 | 0.55744178 |
| 76 | MUSK | 0.55406882 |
| 77 | MAPK4 | 0.54838959 |
| 78 | KSR2 | 0.53526935 |
| 79 | CSNK1E | 0.51731393 |
| 80 | CDK4 | 0.50801608 |
| 81 | MAP3K11 | 0.49593963 |
| 82 | MAP3K13 | 0.49178409 |
| 83 | MAP3K7 | 0.47947788 |
| 84 | PTK6 | 0.47792100 |
| 85 | ZAP70 | 0.45991253 |
| 86 | KIT | 0.45066068 |
| 87 | DYRK1B | 0.43400311 |
| 88 | SRC | 0.43307683 |
| 89 | GSK3A | 0.43199775 |
| 90 | IKBKE | 0.43146884 |
| 91 | CAMK2G | 0.41854915 |
| 92 | CSNK2A1 | 0.40144216 |
| 93 | MET | 0.37663818 |
| 94 | CSNK2A2 | 0.35457043 |
| 95 | CSNK1A1 | 0.35266995 |
| 96 | MAPK15 | 0.33787828 |
| 97 | DYRK1A | 0.32913909 |
| 98 | TGFBR2 | 0.32725140 |
| 99 | SCYL2 | 0.32565216 |
| 100 | MAPK3 | 0.32219708 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.45156624 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.20987255 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.16918177 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.88265580 |
| 5 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.42347786 |
| 6 | * Retinol metabolism_Homo sapiens_hsa00830 | 3.32065815 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.24852102 |
| 8 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.89350252 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.80257362 |
| 10 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.79274571 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.65202927 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55518990 |
| 13 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.53840927 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.51352575 |
| 15 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.51313165 |
| 16 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.42519787 |
| 17 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.40728769 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.23800288 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 2.05552536 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.92577206 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.83714857 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.77421681 |
| 23 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.67503608 |
| 24 | * Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.56271049 |
| 25 | Prion diseases_Homo sapiens_hsa05020 | 1.52547979 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.51128665 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.50408348 |
| 28 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.47753780 |
| 29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.47402207 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.46987842 |
| 31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.43650362 |
| 32 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.34219097 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.33534159 |
| 34 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30004351 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.28118619 |
| 36 | Peroxisome_Homo sapiens_hsa04146 | 1.26026543 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.20868818 |
| 38 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16392205 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.10684358 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.06896461 |
| 41 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.05993592 |
| 42 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.94751210 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.94162827 |
| 44 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90816798 |
| 45 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.87264387 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 0.87136061 |
| 47 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.85983575 |
| 48 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.85580235 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 0.84865080 |
| 50 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.82568622 |
| 51 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.75684973 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.67363472 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.64870541 |
| 54 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.63916356 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.58137121 |
| 56 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.45270902 |
| 57 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.42730446 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.42166844 |
| 59 | Pertussis_Homo sapiens_hsa05133 | 0.39096252 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 0.38888519 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.31125253 |
| 62 | Insulin resistance_Homo sapiens_hsa04931 | 0.26969748 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.24349681 |
| 64 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.21970951 |
| 65 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.21869387 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.17972089 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.16036723 |
| 68 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.12538662 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.09949242 |
| 70 | Amoebiasis_Homo sapiens_hsa05146 | 0.06125491 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.05416827 |
| 72 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.04986066 |
| 73 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.04216703 |
| 74 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.04203431 |
| 75 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03996937 |
| 76 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.01470475 |
| 77 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.01010733 |
| 78 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.2857297 |
| 79 | GABAergic synapse_Homo sapiens_hsa04727 | -0.2840632 |
| 80 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.2461169 |
| 81 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2452706 |
| 82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2369470 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.2263549 |
| 84 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.2199956 |
| 85 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2094949 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.2094079 |
| 87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1865707 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.1638735 |
| 89 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1403817 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1323604 |
| 91 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.1270273 |
| 92 | Steroid biosynthesis_Homo sapiens_hsa00100 | -0.0906392 |
| 93 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0883136 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0666846 |
| 95 | * Serotonergic synapse_Homo sapiens_hsa04726 | -0.0636588 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | -0.0537706 |
| 97 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | -0.0358298 |
| 98 | Galactose metabolism_Homo sapiens_hsa00052 | -0.0184798 |
| 99 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0170088 |
| 100 | Glutathione metabolism_Homo sapiens_hsa00480 | -0.0163321 |

